Metabolomic Profiling of Infectious Parapneumonic Effusions Reveals Biomarkers for Guiding Management of Children with Streptococcus pneumoniae Pneumonia

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Chiu, Chih Yung ^a,b   Lin, Gigin ^a   Cheng, Mei Ling ^a   Chiang, Meng Han ^a   Tsai, Ming Han ^a   Lai, Shen Hao ^a   Wong, Kin Sun ^a   Hsieh, Sen Yung ^b  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

CHEMISTRY; CHILD; COMPLICATION; EXUDATE; HUMAN; METABOLISM; METABOLOME; MICROBIOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY; PLEURA EFFUSION; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE;

BIOMARKERS; CHILD; EXUDATES AND TRANSUDATES; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; METABOLOME; PLEURAL EFFUSION; PNEUMONIA, PNEUMOCOCCAL; STREPTOCOCCUS PNEUMONIAE;

EID: 84964270222     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep24930     Document Type: Article

References (27)

1. Tan, T. Q. Pediatric invasive pneumococcal disease in the United States in the era of pneumococcal conjugate vaccines. Clin Microbiol Rev 25, 409-419 (2012).
2. Lin, T. Y. et al. Etiology of empyema thoracis and parapneumonic pleural effusion in Taiwanese children and adolescents younger than 18 years of age. Pediatr Infect Dis J 32, 419-421 (2013).
3. Hamm, H. & Light, R. W. Parapneumonic effusion and empyema. Eur Respir J 10, 1150-1156 (1997).
4. Chiu, C. Y. et al. Proinflammatory cytokines, fibrinolytic system enzymes, and biochemical indices in children with infectious parapneumonic effusions. Pediatr Infect Dis J 27, 699-703 (2008).
5. Heffner, J. E., Brown, L. K., Barbieri, C. & DeLeo, J. M. Pleural fluid chemical analysis in parapneumonic effusions. A meta-analysis. Am J Respir Crit Care Med 151, 1700-1708 (1995).
6. Light, R. W. A new classification of parapneumonic effusions and empyema. Chest 108, 299-301 (1995).
7. Nilsson, C. L., Puchades, M., Westman, A., Blennow, K. & Davidsson, P. Identification of proteins in a human pleural exudate using two-dimensional preparative liquid-phase electrophoresis and matrix-assisted laser desorption/ionization mass spectrometry. Electrophoresis 20, 860-865 (1999).
8. Tyan, Y. C., Wu, H. Y., Su, W. C., Chen, P. W. & Liao, P. C. Proteomic analysis of human pleural effusion. Proteomics 5, 1062-1074 (2005).
9. Chiu, C. Y. et al. The value of total protein in guiding management of infectious parapneumonic effusion by using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. J Microbiol Immunol Infect 48, 483-489 (2015).
10. Muller, C. et al. Nuclear magnetic resonance spectroscopy with single spin sensitivity. Nat Commun 5, 4703 (2014).
11. Lam, C. W. & Law, C. Y. Untargeted mass spectrometry-based metabolomic profiling of pleural effusions: fatty acids as novel cancer biomarkers for malignant pleural effusions. J Proteome Res 13, 4040-4046 (2014).
12. Lam, C. W. & Law, C. Y. Pleural effusion lipoproteins measured by NMR spectroscopy for diagnosis of exudative pleural effusions: a novel tool for pore-size estimation. J Proteome Res 13, 4104-4112 (2014).
13. Antachopoulos, C. et al. Parapneumonic pleural effusions caused by Streptococcus pneumoniae serotype 3 in children immunized with 13-valent conjugated pneumococcal vaccine. Pediatr Infect Dis J 33, 81-83 (2014).
14. Hoskins, J. et al. Genome of the bacterium Streptococcus pneumoniae strain R6. J Bacteriol 183, 5709-5717 (2001).
15. Tettelin, H. et al. Complete genome sequence of a virulent isolate of Streptococcus pneumoniae. Science 293, 498-506 (2001).
16. Hartel, T. et al. Characterization of central carbon metabolism of Streptococcus pneumoniae by isotopologue profiling. J Biol Chem 287, 4260-4274 (2012).
17. Werno, A. M. & Murdoch, D. R. Medical microbiology: laboratory diagnosis of invasive pneumococcal disease. Clin Infect Dis 46, 926-932 (2008).
18. Cheng, D. S. et al. Comparison of pleural fluid pH values obtained using blood gas machine, pH meter, and pH indicator strip. Chest 114, 1368-1372 (1998).
19. Utine, G. E. et al. Childhood parapneumonic effusions: biochemical and inflammatory markers. Chest 128, 1436-1441 (2005).
20. Chiu, C. Y., Wong, K. S., Huang, Y. C., Lai, S. H. & Lin, T. Y. Echo-guided management of complicated parapneumonic effusion in children. Pediatr Pulmonol 41, 1226-1232 (2006).
21. Van Immerseel, F. et al. Butyric acid-producing anaerobic bacteria as a novel probiotic treatment approach for inflammatory bowel disease. J Med Microbiol 59, 141-143 (2010).
22. Rosenstengel, A. Pleural infection-current diagnosis and management. J Thorac Dis 4, 186-193 (2012).
23. Song, J. Y., Eun, B. W. & Nahm, M. H. Diagnosis of pneumococcal pneumonia: current pitfalls and the way forward. Infect Chemother 45, 351-366 (2013).
24. Bradley, J. S. et al. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis 53, e25-76 (2011).
25. Durbin, B. P., Hardin, J. S., Hawkins, D. M. & Rocke, D. M. A variance-stabilizing transformation for gene-expression microarray data. Bioinformatics 18 Suppl 1, S105-110 (2002).
26. Westerhuis, J. A. et al. Assessment of PLSDA cross validation. Metabolomics 4, 81-89 (2008).
27. Xia, J., Broadhurst, D. I., Wilson, M. & Wishart, D. S. Translational biomarker discovery in clinical metabolomics: an introductory tutorial. Metabolomics 9, 280-299 (2013).